Condition
Microwave Ablation clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Microwave Ablation clinical trials that are recruiting, at sites in 2 countries (most in China (3), United States (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest Microwave Ablation clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| EUS-Guided Ablation for Pancreatic and GI Lesions Registry | — | Morgantown, West Virginia | Recruiting | Jun 4, 2026 |
| Microwave ablation for papillary thyroid microcarcinoma monitored with contrast-enhanced ultrasound and genetic testing | — | Guangzhou, Guangdong | Recruiting | Jul 8, 2025 |
| Using donafenib after thermal ablation for recurrent liver cancer | — | Beijing, None Selected | Recruiting | Sep 24, 2024 |
| Microwave ablation combined with lenvatinib for recurrent liver cancer | — | Changsha, Hunan | Recruiting | Jul 6, 2022 |
All recruiting trials (4)
-
EUS-Guided Ablation for Pancreatic and GI Lesions Registry
This registry collects real-world data on adults undergoing EUS-guided RFA or MWA to treat pancreatic or other GI lesions during routine care to see how these treatments affect lesion size, survival, and symptoms.
-
Microwave ablation for papillary thyroid microcarcinoma monitored with contrast-enhanced ultrasound and genetic testing
This project will try microwave ablation guided by contrast-enhanced ultrasound and an 88-gene panel in adults with low-risk papillary thyroid microcarcinoma to see if it controls the tumor while preserving thyroid function.
-
Using donafenib after thermal ablation for recurrent liver cancer
This study is testing if adding a low dose of donafenib after thermal ablation can help people with early recurrent liver cancer do better than just having the ablation alone.
-
Microwave ablation combined with lenvatinib for recurrent liver cancer
This study is testing whether combining microwave ablation with the drug lenvatinib can help people with recurrent liver cancer feel better and live longer.
Related topics
Quick answers
How many Microwave Ablation clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (3 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.